Stay updated with breaking news from Benjaminj Hindson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eagle Asset Management Inc. trimmed its position in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 0.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 729,476 shares of the company’s stock after selling 5,710 shares during the period. Eagle […]
10x Genomics (NASDAQ:TXG – Free Report) had its target price lowered by Canaccord Genuity Group from $65.00 to $50.00 in a report released on Monday, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other equities analysts have also recently commented on TXG. Deutsche Bank Aktiengesellschaft decreased their price target […]
10x Genomics (NASDAQ:TXG – Free Report) had its price target reduced by The Goldman Sachs Group from $30.00 to $26.00 in a research report released on Wednesday, Benzinga reports. They currently have a sell rating on the stock. A number of other research firms also recently weighed in on TXG. TD Cowen downgraded shares of […]
10x Genomics (NASDAQ:TXG – Free Report) had its price objective lowered by Stifel Nicolaus from $63.00 to $53.00 in a research note released on Wednesday, Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock. Several other research analysts also recently issued reports on TXG. TD Cowen downgraded 10x Genomics from a buy […]
10x Genomics (NASDAQ:TXG – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.50) EPS for the quarter, meeting the consensus estimate of ($0.50), Yahoo Finance reports. 10x Genomics had a negative net margin of 42.20% and a negative return on equity of 30.43%. The company had revenue of $141.01 million […]